Literature DB >> 6192723

Morphometric estimates of infiltrative cellular changes during the development of bleomycin-induced pulmonary fibrosis in hamsters.

D B Chandler, D M Hyde, S N Giri.   

Abstract

The sequence of cellular infiltration into interstitial lung tissue subsequent to intratracheal administration of bleomycin was examined in hamsters. Quantitation of lesions following bleomycin treatment showed a transient increase in the percentage of lung involved, which peaked at 21 days and decreased thereafter. Associated with these lesions was a significant increase in interstitial cell profile density at 21 and 28 days. The total number of cell profiles decreased after 28 days. The cellular composition of the lesion was dominated by monocytes, neutrophils, and macrophages in the initial phase of the fibrosis. Subsequently, monocytes were significantly decreased at 21, 28, and 42 days, as compared with the 7-day value. Similarly, neutrophils were significantly decreased at 21 and 28 days, as compared with the 7-day value. In contrast, macrophages were significantly decreased in the initial phase (7 days) of the cellular infiltration and the later phase at 35 and 42 days, as compared with the value at 4 days after treatment. Lesion composition in the later phase exhibited significant increases in fibroblasts and eosinophils, accompanied by a general increase in lymphocytes. It is concluded that bleomycin-induced inflammatory sequela exhibits temporally based changes in cellular composition of the infiltrate and that the temporal changes in cellularity might be one of the determinants in the pathophysiology of pulmonary fibrosis induced by bleomycin.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6192723      PMCID: PMC1916255     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  37 in total

1.  Granulocyte collagenase: selective digestion of type I relative to type III collagen.

Authors:  A L Horwitz; A J Hance; R G Crystal
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

2.  Lymphokine stimulation of collagen accumulation.

Authors:  R L Johnson; M Ziff
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

Review 3.  Role of granulocyte collagenase in collagen degradation.

Authors:  G S Lazarus; J R Daniels; J Lian; M C Burleigh
Journal:  Am J Pathol       Date:  1972-09       Impact factor: 4.307

4.  A clinical review of bleomycin--a new antineoplastic agent.

Authors:  R H Blum; S K Carter; K Agre
Journal:  Cancer       Date:  1973-04       Impact factor: 6.860

5.  Changes in the composition of lung lipids and the "turnover" of dipalmitoyl lecithin in experimental alveolar lipo-proteinosis induced by inhaled quartz.

Authors:  A G Heppleston; K Fletcher; I Wyatt
Journal:  Br J Exp Pathol       Date:  1974-08

6.  The ultrastructure of 60 Co radiation pneumonitis in rats.

Authors:  C S Faulkner; K S Connolly
Journal:  Lab Invest       Date:  1973-05       Impact factor: 5.662

7.  Mechanism for the inflammatory response in primate lungs. Demonstration and partial characterization of an alveolar macrophage-derived chemotactic factor with preferential activity for polymorphonuclear leukocytes.

Authors:  J A Kazmierowski; J I Gallin; H Y Reynolds
Journal:  J Clin Invest       Date:  1977-02       Impact factor: 14.808

8.  A macrophage-dependent factor that stimulates the proliferation of fibroblasts in vitro.

Authors:  S J Leibovich; R Ross
Journal:  Am J Pathol       Date:  1976-09       Impact factor: 4.307

9.  Comparison of collagenase activity in eosinophil and neutrophil fractions from rat peritoneal exudates.

Authors:  E G Bassett; J R Baker; P A BAKER; D B MYERS
Journal:  Aust J Exp Biol Med Sci       Date:  1976-10

10.  The pathogenesis of bleomycin-induced pulmonary fibrosis in mice.

Authors:  I Y Adamson; D H Bowden
Journal:  Am J Pathol       Date:  1974-11       Impact factor: 4.307

View more
  31 in total

1.  Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis.

Authors:  N Kaminski; J D Allard; J F Pittet; F Zuo; M J Griffiths; D Morris; X Huang; D Sheppard; R A Heller
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

2.  FTS reduces bleomycin-induced cytokine and chemokine production and inhibits pulmonary fibrosis in mice.

Authors:  S Yara; K Kawakami; N Kudeken; M Tohyama; K Teruya; T Chinen; A Awaya; A Saito
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

3.  Failure of bone marrow to reconstitute lung epithelium.

Authors:  Darrell N Kotton; Attila J Fabian; Richard C Mulligan
Journal:  Am J Respir Cell Mol Biol       Date:  2005-06-16       Impact factor: 6.914

4.  Stimulation of rat endothelial cell transforming growth factor-beta production by bleomycin.

Authors:  S H Phan; M Gharaee-Kermani; F Wolber; U S Ryan
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

5.  Overexpression of the transcription factor GATA-3 enhances the development of pulmonary fibrosis.

Authors:  Toru Kimura; Yukio Ishii; Keigyou Yoh; Yuko Morishima; Takashi Iizuka; Takumi Kiwamoto; Yosuke Matsuno; Shinsuke Homma; Akihiro Nomura; Tohru Sakamoto; Satoru Takahashi; Kiyohisa Sekizawa
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

6.  Quantitative immunohistologic assessment of lymphocyte populations in the pulmonary inflammatory response to intratracheal silica.

Authors:  R K Kumar
Journal:  Am J Pathol       Date:  1989-10       Impact factor: 4.307

7.  Development of acute lung injury after the combination of intravenous bleomycin and exposure to hyperoxia in rats.

Authors:  J G Hay; P L Haslam; A Dewar; B Addis; M Turner-Warwick; G J Laurent
Journal:  Thorax       Date:  1987-05       Impact factor: 9.139

8.  Enhanced type III collagen gene expression during bleomycin induced lung fibrosis.

Authors:  S Shahzeidi; B Mulier; B de Crombrugghe; P K Jeffery; R J McAnulty; G J Laurent
Journal:  Thorax       Date:  1993-06       Impact factor: 9.139

9.  Targeted delivery of YSA-functionalized and non-functionalized polymeric nanoparticles to injured pulmonary vasculature.

Authors:  Madhoosudan A Patil; Arun K Upadhyay; Laura Hernandez-Lagunas; Ryan Good; Todd C Carpenter; Carmen C Sucharov; Eva Nozik-Grayck; Uday B Kompella
Journal:  Artif Cells Nanomed Biotechnol       Date:  2018-11-19       Impact factor: 5.678

10.  Cyclin-dependent kinase inhibitors block leukocyte adhesion and migration.

Authors:  Li Liu; Barbara Schwartz; Yoshiaki Tsubota; Elaine Raines; Hiroaki Kiyokawa; Karyn Yonekawa; John M Harlan; Lynn M Schnapp
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.